Search - tctmd.com

Displaying 721 - 740 of 812

Sort: Relevancy | Date

News Daily News

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

December 04, 2011

News Industry News

In patients with diabetes, Cryoplasty post-dilation compared to conventional balloon angioplasty decreases the risk of in-stent restenosis

November 10, 2011

News Industry News

TAVI at TCT: Enthusiasm Tempered by Poor Transapical Outcomes

November 09, 2011

News Conference News

RAPID GENE: Validation of Point-of-Care Genetic Testing

November 09, 2011

News Industry News

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

November 09, 2011

News Conference News

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

November 09, 2011

News Industry News

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

November 08, 2011

News Conference News

Ongoing Trials Explore Potential Benefits of Transradial PCI

November 08, 2011

News Industry News

First clinical trial of point-of-care DNA testing in medicine enables cardiac stent patients to receive personalized antiplatelet therapy

November 08, 2011

News Conference News

Registry Studies Focus on Different TAVR Access Routes

November 07, 2011

News Industry News

Echo May Not Provide Best Picture for TAVI

November 06, 2011

News Conference News

Early Discontinuation of DAPT May Increase Risk of Stent Thrombosis

November 06, 2011

News Industry News

Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT

November 03, 2011

News Daily News

Interventionalists and the Syntax Score—Still Learning

Yael L. Maxwell

November 01, 2011

News Daily News

Better Care Seen for Elderly ACS Patients in England, Wales, But Biases Remain

Yael L. Maxwell

October 27, 2011

News Industry News

PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.

October 14, 2011

News Daily News

Pre-PCI Hydration Feasible, Reduces Kidney Damage in STEMI Patients

Caitlin E. Cox

October 07, 2011

News Daily News

Same-Day Discharge Does Not Affect Death, Rehospitalization Risk After PCI

L.A. McKeown

October 04, 2011

News Daily News

CREST QOL Substudy: Early Advantage with Carotid Stenting Disappears Long-Term

September 26, 2011

News Industry News

PLC Receives Two Additional U.S. Patents and First Japanese Patent For Its RenalGuard® Technology

September 22, 2011

Advertisement

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

In patients with diabetes, Cryoplasty post-dilation compared to conventional balloon angioplasty decreases the risk of in-stent restenosis

TAVI at TCT: Enthusiasm Tempered by Poor Transapical Outcomes

RAPID GENE: Validation of Point-of-Care Genetic Testing

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

Ongoing Trials Explore Potential Benefits of Transradial PCI

First clinical trial of point-of-care DNA testing in medicine enables cardiac stent patients to receive personalized antiplatelet therapy

Registry Studies Focus on Different TAVR Access Routes

Echo May Not Provide Best Picture for TAVI

Early Discontinuation of DAPT May Increase Risk of Stent Thrombosis

Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT

Interventionalists and the Syntax Score—Still Learning

Better Care Seen for Elderly ACS Patients in England, Wales, But Biases Remain

PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.

Pre-PCI Hydration Feasible, Reduces Kidney Damage in STEMI Patients

Same-Day Discharge Does Not Affect Death, Rehospitalization Risk After PCI

CREST QOL Substudy: Early Advantage with Carotid Stenting Disappears Long-Term

PLC Receives Two Additional U.S. Patents and First Japanese Patent For Its RenalGuard® Technology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content